Heart failure and stepdown units of the Sydell and Arnold Miller Family Heart & Vascular Institute have been testing electrocardiogram technology.
A new study finds quantitative delayed hyperenhancement on cardiac MR imaging offers insight into disease duration and expected response to treatment in patients with recurrent pericarditis.
A brief case vignette showcases the clinical setting in which this increasingly popular strain-based heart imaging technique may have its greatest diagnostic and prognostic value.
In this Q&A, Cleveland Clinic’s new Cardiothoracic Surgery Chair shares his vision for the department he now leads, the future of his specialty and collaboration in cardiovascular care.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Both of this year’s lifetime honors in echocardiography went to Cleveland Clinic caregivers — Dr. William Stewart won the physician award and Margaret (Koko) Park earned the sonographer prize.
New studies on male-female differences in response to cardiac resynchronization therapy promise to reshape the way patients are selected to receive CRT devices. The lead investigator explains how.
When a center has an annual vascular surgery case volume beyond 7,500 and one of the largest vascular medicine programs in the U.S., it’s bound to yield some notable stats. Here’s a sampling.
The trial’s new health status analysis gives even more reason to consider CABG the preferred revascularization strategy for patients with anatomically complex three-vessel or left main disease.
The lead investigator of the STS/ACC TVT Registry study presented at ACC.17 explains why its findings suggest valve-in-valve TAVR might be the treatment of choice for inoperable and even high-risk patients.
FOURIER was the big news out of ACC, but other PCSK9 inhibitor trials mattered as well, including its EBBINGHAUS substudy and the SPIRE and ORION-1 trials. Dr. Steven Nissen outlines the takeaways.